Guangdong, China

Zehao Liao

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Longuide Biopharma Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zehao Liao. Retrieved from https://idiyas.com/inventor/zehao-liao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Zehao Liao: Innovator in Lipid Nanoparticle Formulations**

Introduction

Zehao Liao is a notable inventor from Guangdong, China, whose contributions to the field of lipid nanoparticle formulations are paving the way for advancements in nucleic acid delivery methods. With a focus on mRNA delivery, his innovations are poised to significantly impact biopharmaceutical applications.

Latest Patents

Zehao Liao holds one patent titled "Lipids and lipid nanoparticle formulations." This patent encompasses techniques related to lipids and lipid nanoparticle formulations, offering novel ways for the effective delivery of nucleic acids, particularly mRNA.

Career Highlights

Currently, Liao is employed at Longuide Biopharma Corporation, a company dedicated to biopharmaceutical research and development. His expertise plays a crucial role in the ongoing advancements in the delivery systems of various therapeutics.

Collaborations

Throughout his career, Zehao Liao has collaborated with esteemed colleagues, including Longgui Zhang and Yuebao Zhang. These partnerships enhance the research environment and facilitate the development of innovative solutions in the biopharmaceutical sector.

Conclusion

As an inventor, Zehao Liao continues to contribute significantly to the field of lipid formulations and nucleic acid delivery. His work not only reflects his dedication to innovation but also illustrates the potential for groundbreaking advancements in healthcare and biopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…